Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

A prospective study to assess the performance of the improved Boron Neutron Capture Therapy Facility in Argentina.

Provenzano L, Farías RO, Longhino JM, Boggio EF, Herrera MS, Moijsecsiuck N, Fernández C, Santa Cruz GA, González SJ.

Appl Radiat Isot. 2014 Jun;88:171-6. doi: 10.1016/j.apradiso.2013.11.041. Epub 2013 Nov 28.

PMID:
24373821
2.

Voxel model in BNCT treatment planning: performance analysis and improvements.

González SJ, Carando DG, Santa Cruz GA, Zamenhof RG.

Phys Med Biol. 2005 Feb 7;50(3):441-58.

PMID:
15773722
3.

Computational study of the required dimensions for standard sized phantoms in boron neutron capture therapy dosimetry.

Koivunoro H, Auterinen I, Kosunen A, Kotiluoto P, Seppälä T, Savolainen S.

Phys Med Biol. 2003 Nov 7;48(21):N291-300.

PMID:
14653569
4.

Quality assurance procedures for the neutron beam monitors at the FiR 1 BNCT facility.

Auterinen I, Serén T, Kotiluoto P, Uusi-Simola J, Savolainen S.

Appl Radiat Isot. 2004 Nov;61(5):1015-9.

PMID:
15308185
5.

Unifying dose specification between clinical BNCT centers in the Americas.

Riley KJ, Binns PJ, Harling OK, Kiger WS 3rd, González SJ, Casal MR, Longhino J, Larrieu OA, Blaumann HR.

Med Phys. 2008 Apr;35(4):1295-8.

PMID:
18491523
6.

Comparison of quality assurance for performance and safety characteristics of the facility for Boron Neutron Capture therapy in Petten/NL with medical electron accelerators.

Rassow J, Stecher-Rasmussen F, Voorbraak W, Moss R, Vroegindeweij C, Hideghéty K, Sauerwein W.

Radiother Oncol. 2001 Apr;59(1):99-108. Review.

PMID:
11295213
7.

Toward a clinical application of ex situ boron neutron capture therapy for lung tumors at the RA-3 reactor in Argentina.

Farías RO, Garabalino MA, Ferraris S, Santa María J, Rovati O, Lange F, Trivillin VA, Monti Hughes A, Pozzi EC, Thorp SI, Curotto P, Miller ME, Santa Cruz GA, Bortolussi S, Altieri S, Portu AM, Saint Martin G, Schwint AE, González SJ.

Med Phys. 2015 Jul;42(7):4161-73. doi: 10.1118/1.4922158.

PMID:
26133616
8.

Normalisation of prescribed dose in BNCT.

Binns PJ, Riley KJ, Harling OK, Albritton JR, Kiger WS 3rd.

Radiat Prot Dosimetry. 2007;126(1-4):610-4. Epub 2007 May 23.

PMID:
17522033
9.

Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer.

Pozzi E, Nigg DW, Miller M, Thorp SI, Heber EM, Zarza L, Estryk G, Monti Hughes A, Molinari AJ, Garabalino M, Itoiz ME, Aromando RF, Quintana J, Trivillin VA, Schwint AE.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S309-12. doi: 10.1016/j.apradiso.2009.03.069. Epub 2009 Mar 27.

PMID:
19380233
10.

Verification of the computational dosimetry system in JAERI (JCDS) for boron neutron capture therapy.

Kumada H, Yamamoto K, Matsumura A, Yamamoto T, Nakagawa Y, Nakai K, Kageji T.

Phys Med Biol. 2004 Aug 7;49(15):3353-65.

PMID:
15379018
11.

BNCT dose calculation in irregular fields using the sector integration method.

Blaumann HR, Sanz DE, Longhino JM, Larrieu OA.

Appl Radiat Isot. 2004 Nov;61(5):835-40.

PMID:
15308153
12.

Evaluation of performance of an accelerator-based BNCT facility for the treatment of different tumor targets.

Herrera MS, González SJ, Minsky DM, Kreiner AJ.

Phys Med. 2013 Sep;29(5):436-46. doi: 10.1016/j.ejmp.2013.01.006. Epub 2013 Feb 23.

PMID:
23462279
13.

Dose-rate scaling factor estimation of THOR BNCT test beam.

Hsu FY, Tung CJ, Chen JC, Wang YL, Huang HC, Zamenhof RG.

Appl Radiat Isot. 2004 Nov;61(5):881-5.

PMID:
15308162
14.

Boron neutron capture therapy (BNCT) in Finland: technological and physical prospects after 20 years of experiences.

Savolainen S, Kortesniemi M, Timonen M, Reijonen V, Kuusela L, Uusi-Simola J, Salli E, Koivunoro H, Seppälä T, Lönnroth N, Välimäki P, Hyvönen H, Kotiluoto P, Serén T, Kuronen A, Heikkinen S, Kosunen A, Auterinen I.

Phys Med. 2013 May;29(3):233-48. doi: 10.1016/j.ejmp.2012.04.008. Epub 2012 May 20. Review.

PMID:
22613369
15.

Quality assurance of patient dosimetry in boron neutron capture therapy.

Munck af Rosenschöld PM, Capala J, Ceberg CP, Giusti V, Salford LG, Persson BR.

Acta Oncol. 2004;43(4):404-11.

PMID:
15303503
16.
17.

First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome.

González SJ, Bonomi MR, Santa Cruz GA, Blaumann HR, Calzetta Larrieu OA, Menéndez P, Jiménez Rebagliati R, Longhino J, Feld DB, Dagrosa MA, Argerich C, Castiglia SG, Batistoni DA, Liberman SJ, Roth BM.

Appl Radiat Isot. 2004 Nov;61(5):1101-5.

PMID:
15308199
18.

Characteristics of the new THOR epithermal neutron beam for BNCT.

Tung CJ, Wang YL, Hsu FY, Chang SL, Liu YW.

Appl Radiat Isot. 2004 Nov;61(5):861-4.

PMID:
15308158
19.

Comparison of the performance of two NCT treatment planning systems using the therapeutic beam of the RA-6 reactor.

Casal MR, González SJ, Blaumann HR, Longhino J, Calzetta Larrieu OA, Wemple CA.

Appl Radiat Isot. 2004 Nov;61(5):805-10.

PMID:
15308148
20.

Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine.

Joensuu H, Kankaanranta L, Seppälä T, Auterinen I, Kallio M, Kulvik M, Laakso J, Vähätalo J, Kortesniemi M, Kotiluoto P, Serén T, Karila J, Brander A, Järviluoma E, Ryynänen P, Paetau A, Ruokonen I, Minn H, Tenhunen M, Jääskeläinen J, Färkkilä M, Savolainen S.

J Neurooncol. 2003 Mar-Apr;62(1-2):123-34.

PMID:
12749708

Supplemental Content

Support Center